CANCELED - HDAC inhibition as a HFpEF treatment

Friday, October 25, 2019 - 12:00pm
Event Location: 

Sarver Heart Center, Room 4137

Steven Houser, PhD, FAHA

"HDAC inhibition as a HFpEF treatment"

Dr. Houser is an internationally respected cardiovascular researcher who has been a Temple faculty member for more than three decades. His research group has helped define many fundamental features of the normal cardiac myocyte as well as identified defective molecular and cellular processes that produce abnormal cardiac myocyte function in cardiovascular disease. This group was awarded a five-year, $11.6 million grant from the National Heart, Lung and Blood Institute of the National Institutes of Health in 2012 to develop new approaches to prevent, slow or reverse damage to the heart after a heart attack.

Dr. Houser earned his PhD in Physiology and completed a research fellowship at TUSM. He joined the Temple faculty as an Assistant Professor of Physiology in 1979 and was named Director of the Cardiovascular Research Center in 2003 and Chair of Physiology in 2006. He has a long association with the American Heart Association, serving as a board member, Chair of the Research Committee, and President of the Southeastern Pennsylvania Affiliate. He has also served on a number of national AHA committees. He was Past President of AHA 2017-2018.

In addition to being Senior Associate Dean of Research, the Vera J. Goodfriend Endowed Chair of Cardiovascular Research and Director of the Cardiovascular Research Center, Dr. Houser is also Professor and Chair of the Department of Physiology at Temple University Lewis Katz School of Medicine.

Event Coordinator: 
Gilbert Maldonado
(520) 626-2000
Event Contact Department: 
Sarver Heart Center